Male fertility a matter of cell signals

September 14, 2010

Australian scientists have discovered the chemical signals that ensure men produce sperm instead of eggs.

Dr. Josephine Bowles and Professor Peter Koopman from UQ's Institute for Molecular Bioscience led a team that found that a protein called FGF9 promotes the production of sperm in males while suppressing the development of .

“It sounds obvious, that men produce sperm and women produce eggs,” Dr. Bowles said.

“But sperm and eggs start out as identical cells, and it's only through a complex process of signals that these cells end up as sperm in men and eggs in women.

“It's a critical process because if people don't produce the right type of reproductive cell, they can develop or even cancer.”

This work follows an earlier study by the team, who identified the molecule responsible for causing eggs to develop in females: retinoic acid, a derivative of Vitamin A.

In this new study, they investigated sperm development in more detail to see whether it was triggered by an absence of retinoic acid, or whether there was a further factor at work in males.

The team identified FGF9 as a possible influencer because it is active in the male gonad around the same time as sperm development begins.

The researchers studied the workings of FGF9 in male and female gonads, including in mice that lacked the protein and those in which FGF9 was expressed at abnormally high levels.

They found that the protein acts directly on the in males, making them less responsive to retinoic acid and actively promoting sperm development.

“It now appears that whilst retinoic acid pushes reproductive cells towards developing as eggs, FGF9 opposes this process and drives them towards becoming sperm,” Dr. Bowles said.

“It means there is a failsafe built into the system. If a female is lacking retinoic acid, it doesn't mean her reproductive cells will develop into sperm because she won't have FGF9 to trigger spermatogenesis.

“Retinoic acid is more abundant in the developing ovary and FGF9 is more abundant in the developing testis, so the crucial decision of whether a reproductive cell commits to becoming an egg or a is determined by the type of gonad in which it is located.”

The discovery has added a new layer of understanding to the process of reproductive cell development and could lead to improved IVF and a greater understanding of how to control stem cells.

The research was supported by grants from the Australian Research Council and the National Health and Medical Research Council of Australia.

Related Stories

Recommended for you

Scientists find key to regenerating blood vessels

November 23, 2017
A new study led by researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) identifies a signaling pathway that is essential for angiogenesis, the growth of new blood vessels from pre-existing vessels. The ...

Researchers find infectious prions in Creutzfeldt-Jakob disease patient skin

November 22, 2017
Creutzfeldt-Jakob disease (CJD)—the human equivalent of mad cow disease—is caused by rogue, misfolded protein aggregates termed prions, which are infectious and cause fatal damages in the patient's brain. CJD patients ...

Surprising roles for muscle in tissue regeneration, study finds

November 22, 2017
A team of researchers at Whitehead has illuminated an important role for different subtypes of muscle cells in orchestrating the process of tissue regeneration. In a paper published in the November 22 issue of Nature, they ...

Study reveals new mechanisms of cell death in neurodegenerative disorders

November 22, 2017
Researchers at King's College London have discovered new mechanisms of cell death, which may be involved in debilitating neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease.

Cinnamon turns up the heat on fat cells

November 21, 2017
New research from the University of Michigan Life Sciences Institute has determined how a common holiday spice—cinnamon—might be enlisted in the fight against obesity.

How rogue immune cells cross the blood-brain barrier to cause multiple sclerosis

November 21, 2017
Drug designers working on therapeutics against multiple sclerosis should focus on blocking two distinct ways rogue immune cells attack healthy neurons, according to a new study in the journal Cell Reports.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.